149 related articles for article (PubMed ID: 36989333)
1. Consistently low levels of histidine-rich glycoprotein as a new prognostic biomarker for sepsis: A multicenter prospective observational study.
Kawanoue N; Kuroda K; Yasuda H; Oiwa M; Suzuki S; Wake H; Hosoi H; Nishibori M; Morimatsu H;
PLoS One; 2023; 18(3):e0283426. PubMed ID: 36989333
[TBL] [Abstract][Full Text] [Related]
2. Histidine-rich glycoprotein as a novel predictive biomarker of postoperative complications in intensive care unit patients: a prospective observational study.
Oiwa M; Kuroda K; Kawanoue N; Morimatsu H
BMC Anesthesiol; 2022 Jul; 22(1):232. PubMed ID: 35858852
[TBL] [Abstract][Full Text] [Related]
3. Histidine-rich glycoprotein as a prognostic biomarker for sepsis.
Kuroda K; Ishii K; Mihara Y; Kawanoue N; Wake H; Mori S; Yoshida M; Nishibori M; Morimatsu H
Sci Rep; 2021 May; 11(1):10223. PubMed ID: 33986340
[TBL] [Abstract][Full Text] [Related]
4. Decrease in Histidine-Rich Glycoprotein as a Novel Biomarker to Predict Sepsis Among Systemic Inflammatory Response Syndrome.
Kuroda K; Wake H; Mori S; Hinotsu S; Nishibori M; Morimatsu H
Crit Care Med; 2018 Apr; 46(4):570-576. PubMed ID: 29303798
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.
Lee S; Song J; Park DW; Seok H; Ahn S; Kim J; Park J; Cho HJ; Moon S
BMC Infect Dis; 2022 Jan; 22(1):8. PubMed ID: 34983420
[TBL] [Abstract][Full Text] [Related]
6. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.
Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L;
Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424
[TBL] [Abstract][Full Text] [Related]
7. A novel biomarker of serum Histidine-Rich Glycoprotein (HRG) for diagnosing and predicting prognosis of ventilator-associated pneumonia (VAP): a pilot study.
Ding HG; Zhou HF; Diao MY; Xu Y; Pan QM; Shen XH
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7920-7927. PubMed ID: 30536339
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of serum presepsin level in pneumonia focal sepsis and its relationship with other biomarkers and clinical severity scores.
Ozkan S; Kahveci U; Hur I; Halici A
Saudi Med J; 2021 Sep; 42(9):994-1001. PubMed ID: 34470838
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Histidine rich glycoprotein, a novel biomarker for sepsis, with traditional biomarkers in adult ICU patients.
Fouad MA; Abd Elrahman AH; El-Melouk MS
Egypt J Immunol; 2022 Apr; 29(2):41-47. PubMed ID: 35436053
[TBL] [Abstract][Full Text] [Related]
10. Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients.
Hassan EA; Abdel Rehim AS; Ahmed AO; Abdullahtif H; Attia A
Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30717340
[TBL] [Abstract][Full Text] [Related]
11. The role of plasma presepsin levels in determining the incidence of septic shock and mortality in patients with sepsis.
Kahveci U; Ozkan S; Melekoglu A; Usul E; Ozturk G; Cetin E; Abatay K; Sahin A
J Infect Dev Ctries; 2021 Jan; 15(1):123-130. PubMed ID: 33571154
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.
Park M; Hur M; Kim H; Lee CH; Lee JH; Kim HW; Nam M
Ann Lab Med; 2022 Jul; 42(4):406-414. PubMed ID: 35177561
[TBL] [Abstract][Full Text] [Related]
13. Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis.
Chen M; Zhu Y
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255294
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S
Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Roles of C-Reactive Protein, Procalcitonin, and Presepsin in Acute Kidney Injury Patients Initiating Continuous Renal Replacement Therapy.
Han S; Kim MJ; Ko HJ; Lee EJ; Kim HR; Jeon JW; Ham YR; Na KR; Lee KW; Lee SI; Choi DE; Park H
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832265
[TBL] [Abstract][Full Text] [Related]
18. Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit.
Wang S; Ruan WQ; Yu Z; Zhao X; Chen ZX; Li Q
Minerva Anestesiol; 2020 Nov; 86(11):1170-1179. PubMed ID: 32959628
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.
Liu B; Chen YX; Yin Q; Zhao YZ; Li CS
Crit Care; 2013 Oct; 17(5):R244. PubMed ID: 24138799
[TBL] [Abstract][Full Text] [Related]
20. Presepsin values as markers of severity of sepsis.
Aliu-Bejta A; Atelj A; Kurshumliu M; Dreshaj S; Baršić B
Int J Infect Dis; 2020 Jun; 95():1-7. PubMed ID: 32251795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
